High Sierra Technologies, Inc. (HSTI)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -323.95 Thousand USD | -8.65% |
| 2021 | -376.94 Thousand USD | -6.75% |
| 2020 | -353.11 Thousand USD | 27.91% |
| 2019 | -489.84 Thousand USD | -1052.06% |
| 2018 | -42.51 Thousand USD | 7.72% |
| 2017 | -46.07 Thousand USD | -11.73% |
| 2016 | -41.23 Thousand USD | 20.55% |
| 2015 | -51.9 Thousand USD | -29.77% |
| 2014 | -40 Thousand USD | -33.33% |
| 2013 | -30 Thousand USD | 0.0% |
| 2012 | -30 Thousand USD | 0.0% |
| 2011 | -30 Thousand USD | -50.0% |
| 2010 | -20 Thousand USD | 0.0% |
| 2009 | -20 Thousand USD | 0.0% |
| 2008 | -20 Thousand USD | 0.0% |
| 2007 | -20 Thousand USD | 35.54% |
| 2006 | -31.02 Thousand USD | -149.87% |
| 2005 | -12.41 Thousand USD | -32.31% |
| 2004 | -9385.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -95.03 Thousand USD | 32.19% |
| 2023 Q2 | -96 Thousand USD | -1.02% |
| 2023 Q3 | -94.48 Thousand USD | 1.58% |
| 2022 Q1 | -114.05 Thousand USD | -230.25% |
| 2022 FY | -409.54 Thousand USD | -8.65% |
| 2022 Q4 | -140.15 Thousand USD | -167.43% |
| 2022 Q3 | -52.4 Thousand USD | -0.94% |
| 2022 Q2 | -51.92 Thousand USD | 54.48% |
| 2021 Q1 | -84.74 Thousand USD | 57.29% |
| 2021 Q4 | -34.53 Thousand USD | 74.41% |
| 2021 FY | -376.94 Thousand USD | -6.75% |
| 2021 Q2 | -62.2 Thousand USD | 26.59% |
| 2021 Q3 | -134.94 Thousand USD | -116.92% |
| 2020 Q1 | -28.21 Thousand USD | -181.54% |
| 2020 Q3 | -46.81 Thousand USD | -46.01% |
| 2020 Q2 | -32.06 Thousand USD | -13.66% |
| 2020 FY | -353.11 Thousand USD | 27.91% |
| 2020 Q4 | -198.41 Thousand USD | -323.8% |
| 2019 FY | -489.84 Thousand USD | -1052.06% |
| 2019 Q3 | -177.22 Thousand USD | 35.97% |
| 2019 Q1 | -56.82 Thousand USD | -33.65% |
| 2019 Q2 | -276.79 Thousand USD | -387.07% |
| 2019 Q4 | 34.6 Thousand USD | 119.52% |
| 2018 Q4 | -42.52 Thousand USD | -182.63% |
| 2018 Q1 | -6512.00 USD | 32.76% |
| 2018 Q3 | 51.45 Thousand USD | 381.84% |
| 2018 Q2 | -18.25 Thousand USD | -180.37% |
| 2018 FY | -42.51 Thousand USD | 7.72% |
| 2017 Q3 | -9815.00 USD | 43.14% |
| 2017 FY | -46.07 Thousand USD | -11.73% |
| 2017 Q4 | -9685.00 USD | 1.32% |
| 2017 Q2 | -17.26 Thousand USD | -85.3% |
| 2017 Q1 | -9315.00 USD | -2.24% |
| 2016 Q4 | -9111.00 USD | 13.97% |
| 2016 Q3 | -10.59 Thousand USD | 26.06% |
| 2016 FY | -41.23 Thousand USD | 20.55% |
| 2016 Q2 | -14.32 Thousand USD | -98.54% |
| 2016 Q1 | -7214.00 USD | 29.61% |
| 2015 Q2 | -21.66 Thousand USD | -177.15% |
| 2015 Q1 | -7816.00 USD | 34.06% |
| 2015 Q4 | -10.24 Thousand USD | 15.86% |
| 2015 FY | -51.9 Thousand USD | -29.77% |
| 2015 Q3 | -12.18 Thousand USD | 43.77% |
| 2014 FY | -40 Thousand USD | -33.33% |
| 2014 Q4 | -11.85 Thousand USD | -16.13% |
| 2014 Q3 | -10.2 Thousand USD | -68.52% |
| 2014 Q2 | -6057.00 USD | 37.22% |
| 2014 Q1 | -9648.00 USD | -31.46% |
| 2013 Q1 | -4121.00 USD | 40.9% |
| 2013 Q2 | -12.86 Thousand USD | -212.28% |
| 2013 Q3 | -7911.00 USD | 38.53% |
| 2013 Q4 | -7339.00 USD | 7.23% |
| 2013 FY | -30 Thousand USD | 0.0% |
| 2012 FY | -30 Thousand USD | 0.0% |
| 2012 Q3 | -8400.00 USD | -27.54% |
| 2012 Q2 | -6586.00 USD | 8.29% |
| 2012 Q4 | -6973.00 USD | 16.99% |
| 2012 Q1 | -7181.00 USD | 5.92% |
| 2011 Q1 | -8083.00 USD | -65.87% |
| 2011 Q2 | -5831.00 USD | 27.86% |
| 2011 Q3 | -5378.00 USD | 7.77% |
| 2011 FY | -30 Thousand USD | -50.0% |
| 2011 Q4 | -7633.00 USD | -41.93% |
| 2010 Q3 | -4139.00 USD | 45.4% |
| 2010 Q2 | -7580.00 USD | -51.84% |
| 2010 Q1 | -4992.00 USD | -11.53% |
| 2010 FY | -20 Thousand USD | 0.0% |
| 2010 Q4 | -4873.00 USD | -17.73% |
| 2009 Q3 | -4044.00 USD | 28.79% |
| 2009 Q2 | -5679.00 USD | 18.92% |
| 2009 Q1 | -7004.00 USD | -96.25% |
| 2009 Q4 | -4476.00 USD | -10.68% |
| 2009 FY | -20 Thousand USD | 0.0% |
| 2008 Q1 | -5494.00 USD | -63.32% |
| 2008 Q4 | -3569.00 USD | 0.08% |
| 2008 Q3 | -3572.00 USD | 49.55% |
| 2008 Q2 | -7080.00 USD | -28.87% |
| 2008 FY | -20 Thousand USD | 0.0% |
| 2007 Q1 | -7038.00 USD | -168.63% |
| 2007 Q2 | -8774.00 USD | -24.67% |
| 2007 FY | -20 Thousand USD | 35.54% |
| 2007 Q3 | -3218.00 USD | 63.32% |
| 2007 Q4 | -3364.00 USD | -4.54% |
| 2006 Q4 | -2620.00 USD | 70.29% |
| 2006 Q3 | -8819.00 USD | 52.51% |
| 2006 Q1 | -1017.00 USD | 75.37% |
| 2006 FY | -31.02 Thousand USD | -149.87% |
| 2006 Q2 | -18.57 Thousand USD | -1726.06% |
| 2005 Q1 | -1364.00 USD | 0.0% |
| 2005 Q2 | -5565.00 USD | -307.99% |
| 2005 Q3 | -1359.00 USD | 75.58% |
| 2005 Q4 | -4129.00 USD | -203.83% |
| 2005 FY | -12.41 Thousand USD | -32.31% |
| 2004 FY | -9385.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BioQuest Corp. | -123.33 USD | -262570.883% |
| GSRX Industries Inc. | - USD | Infinity% |
| Instadose Pharma Corp. | - USD | Infinity% |